Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques
Sensory Analysis and Cutaneous Mapping of Different Regional Anesthesia Techniques in Laparoscopic Cholecystectomy Surgery: A Prospective Observational Study
Samsun University
40 participants
Nov 15, 2025
OBSERVATIONAL
Conditions
Summary
This prospective observational study aims to evaluate and compare the sensory block distribution and regression patterns of two regional anesthesia techniques - External Oblique Plane Block (EOPB) and Serratus Intercostal Plane Block (SIPB) - in patients undergoing laparoscopic cholecystectomy. Thirty adult patients (ASA I-III, BMI ≤ 35 kg/m², ≥50 kg) scheduled for elective laparoscopic cholecystectomy procedures will be included, with 20 in each block group. Sensory block areas will be assessed using pinprick test, and dermatomal mapping will visualize the spread. The findings are expected to improve understanding of block behavior and guide multimodal analgesia strategies in laparoscopic cholecystectomy.
Eligibility
Inclusion Criteria4
- Patients scheduled for elective laparoscopic cholecystectomy surgery and who have received a regional anesthesia technique for this purpose.
- Aged between 18-75 years.
- Belonging to ASA I-III group.
- Having provided written informed consent.
Exclusion Criteria7
- Patients who refuse to participate.
- Patients who did not receive a block.
- Patients classified as ASA IV.
- History of previous abdominal surgery (affecting the laparoscopic approach).
- Patients with cognitive dysfunction or inability to cooperate.
- Patients diagnosed with psychiatric disorders (schizophrenia, mania, depression, etc.).
- Patients who have been using antipsychotic medication for more than 4 weeks.
Interventions
Ultrasound-guided External Oblique Plane Block (EOPB) performed bilaterally using 0.25% bupivacaine (25 mL per side, total 50 mL) for postoperative analgesia in laparoscopic cholecystectomy.
Ultrasound-guided Serratus Intercostal Plane Block (SIPB) performed bilaterally using 0.25% bupivacaine (25 mL per side, total 50 mL) for postoperative analgesia in laparoscopic cholecystectomy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07445854